Learn when your baby is ready for solids, choose safe purees or finger foods, prevent choking, prioritize iron, and introduce allergens confidently.
|Articles|May 13, 2019
May 2019 Digital Edition
Advertisement
Between the covers of this issue, you'll discover what to do in a neurologic emergency, how pediatric drug development has changed, and the latest in vision screening technology.
Advertisement
Related to this article
An updated AAP policy statement renews the call to ban raw milk sales, citing pathogen risks to children and pregnant people and an emerging H5N1 concern.
In a meta-analysis of 46 RCTs, behavioral interventions modestly improved HbA1c in youth with T1D; family-focused approaches worked best.
A GBD analysis of 204 countries estimated measles cases in children under 5 rose from 11.1 million in 2019 to 15.6 million in 2023.
Missed the AAP's new pediatric UTI guideline? This easy-to-read FAQ covers the key changes in diagnosis, treatment, imaging, and prevention.
Christina Boull, MD, explains how pediatricians can recognize dermatologic conditions in darker skin tones and address pigment changes and treatment gaps.
Tezepelumab produced histologic remission in up to 68.9% of patients aged 12+ with EoE vs 3.5% with placebo at week 24, sustained to week 52.
Black race was the strongest predictor of T2-high inflammation in 451 children with severe asthma adjusted for social and environmental factors.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Global measles cases in children under 5 up 40% since COVID-19
2
Recognizing skin conditions in children with darker skin tones
3
FAQ: How should pediatricians manage UTIs under new AAP guidance?
4
Tezepelumab sustains EoE remission through 52 weeks
5